Detail akcie Agilent Tech online

Business Summary: Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Financial Summary: BRIEF: For the fiscal year ended 31 October 2019, Agilent Technologies Inc revenues increased 5% to $5.16B. Net income before extraordinary items increased 23% to $1.07B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Interest Expense decrease of 1% to $74M (expense). Dividend per share increased from $0.58 to $0.64.